Saasbyt

Biotech

The Breakthrough in Lung Cancer Treatment: Reflexion

Lung Cancer Treatment

Reflexion: Lung Cancer Treatment | Biology-guided Radiotherapy | Biotech
RefleXion Medical, led by Todd Powell, president, and CEO, is developing the RefleXion X1 machine (for Lung Cancer Treatment), a biology-guided radiotherapy system that is cleared for stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS), and intensity-modulated radiation (IMRT). BgRT, includes positron-emission tomography (PET) imaging data to enable tumors to continually broadcast their position. The BgRT system will synchronize this data with the linear accelerator, allowing for a subsecond delay in radiation delivery to malignancies. Because of its ability to identify and treat moving targets, BgRT was recently designated as a Breakthrough Device by the US Food and Drug Administration (FDA) for use in lung cancers.

Features:
– Real-time Guidance
– Targeting Cancer
– Metastatic Disease
– Combination Treatment

In short, RefleXion’s biology-guided radiotherapy (BgRT) allows us to detect and respond to signals emitted from cancer itself, and for the first time, use them to guide immediate treatment.

2 thoughts on “The Breakthrough in Lung Cancer Treatment: Reflexion

  1. Nice post. I learn something new and challenging on blogs I stumbleupon everyday. It will always be helpful to read content from other authors and use something from their websites.

Leave a Reply

Your email address will not be published. Required fields are marked *